Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Warrington, Pennsylvania 18976


Purpose:

Treatment with lucinactant, a peptide-containing synthetic lung surfactant, will be evaluated in young children with acute respiratory failure who require mechanical ventilation (life support), to determine if it is safe and if treatment with lucinactant will reduce the number of days a child needs mechanical ventilation (life support).


Study summary:

Determine the safety and tolerability of administration of a peptide-containing synthetic lung surfactant, lucinactant, in children up to two years of age and assess whether treatment with lucinactant can decrease the duration of mechanical ventilation in young children.


Criteria:

Inclusion Criteria: - ≥ 38 weeks (corrected age) to 2 years (24 months) - Intubated and mechanically ventilated (MV) for ≥ 6 hours and anticipated need for MV for ≥ 24 hours - Persistent hypoxia - Written informed consent Exclusion Criteria: - Mechanical Ventilation for > 48 hours - Oxygenation index ≥ 25, if arterial line was avialable - Pre-existing clinically significant or palliated/uncorrected cardiac disease adversely affecting cardiopulmonary function and gas exchange - Neuromuscular disease or hypotonia - Upper airway disease - Baseline requirment for supplemental oxygen - Untreated pneumothorax - Off-label use of commercially available surfactant outside neonatal period - History of prematurity and passive immunoprophylaxis with humanized monoclonal antibody - Head injury with Glasgow Coma Scale < 8 - Brain death or impending brain death - Do not resuscitate orders - Cardiopulmonary resuscitation within 6 hours of meeting entry criteria - Experimental therapy in which the intervention potentially affects respiratory outcomes - Any transplant recipient - Meconium aspiration syndrome - Bordetella pertussis infection confirmed via laboratory tests and/or highly suspected pertussis infection


NCT ID:

NCT00578734


Primary Contact:

Principal Investigator
Neal Thomas, MD
Penn State Children's Hospital


Backup Contact:

N/A


Location Contact:

Warrington, Pennsylvania 18976
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.